Fig. 3

Effects of the aqueous extract from Markhamia tomentosa stem bark (50 and 200 mg/kg) on AChE (a), SOD (b) and GPX (c) specific activities, on reduced GSH (d), protein carbonyl (e) and MDA (f) levels in the scopolamine-treated rats. Values are mean ± SEM. (n = 5 animals per group). For Tukey’s post hoc analysis—^#Control vs. Sco: p < 0.01, ^#Sco vs. Sco+ME (50 mg/kg): p < 0.01 and ^##Sco vs. Sco+ME (200 mg/kg: p < 0.001 (a), ^###Control vs. Sco: p < 0.0001, ^##Sco vs. Sco+ME (50 mg/kg): p < 0.001 and ^###Sco vs. Sco+ME (200 mg/kg): p < 0.0001 (b), ^###Control vs. Sco: p < 0.0001, ^###Control vs. Sco+ME (50 mg/kg): p < 0.0001, ^###Control vs. Sco+ME (200 mg/kg): p < 0.0001, ^#Sco vs. Sco+ME (50 mg/kg): p < 0.01 and ^##Sco vs. Sco+ME (200 mg/kg): p < 0.001 (c), ^#Control vs. Sco: p < 0.01, ^#Sco vs. Sco+ME (50 mg/kg): p < 0.01 and ^##Sco vs. Sco+ME (200 mg/kg): p < 0.001 (d), ^##Control vs. Sco: p < 0.0001, ^##Sco vs. Sco+ME (50 mg/kg): p < 0.0001 and ^###Sco vs. Sco+ME (200 mg/kg): p < 0.00001 (e) and ^##Control vs. Sco: p < 0.0001, ^##Sco vs. Sco+ME (50 mg/kg): p < 0.0001 and ^###Sco vs. Sco+ME (200 mg/kg): p < 0.00001 (f)